Adverse Events Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module

Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2025-12-26 @ 3:14 AM
NCT ID: NCT00703820
Description: None
Frequency Threshold: 5
Time Frame: Participants were monitored from the start of therapy through 30 days after this protocol's treatment plan was completed. Participants who received NK cell infusions were followed until any identified toxicities resolved to less than grade 2. Donors were followed for adverse events from the day of apheresis through seven days following apheresis.
Study: NCT00703820
Study Brief: Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Cytarabine+Daunorubicin+Etoposide Participants received Cytarabine + Daunorubicin + Etoposide as their first course of chemotherapy. Subsequent therapy is risk-adapted. 43 None 127 133 9 133 View
Clofarabine+Cytarabine Participants received Clofarabine + Cytarabine as their first course of chemotherapy. Subsequent therapy is risk-adapted. 32 None 122 129 9 129 View
Stem Cell Donors This group enrolled in the study to provide donor cells to participants. Donors did not receive therapy. 0 None 0 29 0 29 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Neuropathy: cranial, CN VI lateral deviation of eye SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Seizure SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Ataxia (incoordination) SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Speech impairment (e.g., dysphasia or aphasia) SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
CNS cerebrovascular ischemia SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
CNS necrosis/cystic progression SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Somnolence/depressed level of consciousness SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Neurology - other SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Neuropathy: cranial, CN IX Motor-pharynx; sensory-ear, pharynx, tongue SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Vasovagal episode SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Infection (documented clinically or microbiologically documented, ANC<1.0x10e9/L, fever>38.5C),blood SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Infection (documented clinically or microbioogically) with Grade 3 or 4 neutrophils (ANC<1.0x10e9/L) SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Infection - other SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Infection with normal ANC or Grade 1 or 2 neutrophils SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Infection with unknown ANC, blood SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Infection with unknown ANC, lung (pneumonia) SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Infection with unknown ANC, catheter-related SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Infection with unknown ANC, lip/perioral SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Allergic reaction/hypersensitivity (including drug fever) SYSTEMATIC_ASSESSMENT Immune system disorders CTCAE v. 3.0 View
Allergy/immunology - other SYSTEMATIC_ASSESSMENT Immune system disorders CTCAE v. 3.0 View
Allergic reaction to Asparaginase SYSTEMATIC_ASSESSMENT Immune system disorders CTCAE v. 3.0 View
Urinary retention (including neurogenic bladder) SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v. 3.0 View
Mood alteration, anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE v. 3.0 View
Febrile neutropenia (fever of unknown origin: not clinically or microbiologically documented) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE v. 3.0 View
Mood alteration, depression SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE v. 3.0 View
DIC (disseminated intravascular coagulation) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE v. 3.0 View
Neutrophils/granulocytes (ANC/AGC) SYSTEMATIC_ASSESSMENT Eye disorders CTCAE v. 3.0 View
Ocular/visual - other SYSTEMATIC_ASSESSMENT Eye disorders CTCAE v. 3.0 View
Ocular surface disease SYSTEMATIC_ASSESSMENT Eye disorders CTCAE v. 3.0 View
Keratitis (corneal inflammation/corneal ulceration) SYSTEMATIC_ASSESSMENT Eye disorders CTCAE v. 3.0 View
Vision-photophobia SYSTEMATIC_ASSESSMENT Eye disorders CTCAE v. 3.0 View
Optic disc edema SYSTEMATIC_ASSESSMENT Eye disorders CTCAE v. 3.0 View
Death not associated with CTCAE term, multi-organ failure SYSTEMATIC_ASSESSMENT General disorders CTCAE v. 3.0 View
Constitutional symptoms - other SYSTEMATIC_ASSESSMENT General disorders CTCAE v. 3.0 View
Weight loss SYSTEMATIC_ASSESSMENT General disorders CTCAE v. 3.0 View
Injection site reaction/extravasation changes SYSTEMATIC_ASSESSMENT General disorders CTCAE v. 3.0 View
Pain - other SYSTEMATIC_ASSESSMENT General disorders CTCAE v. 3.0 View
Personality/behavioral SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE v. 3.0 View
Mood alteration, agitation SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE v. 3.0 View
Mood alteration, euphoria SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE v. 3.0 View
Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0x10e9/L) SYSTEMATIC_ASSESSMENT General disorders CTCAE v. 3.0 View
Edema: head and neck SYSTEMATIC_ASSESSMENT General disorders CTCAE v. 3.0 View
Death not associated with CTCAE term, sudden death SYSTEMATIC_ASSESSMENT General disorders CTCAE v. 3.0 View
Hypoxia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Pulmonary/upper respiratory - other SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Dyspnea (shortness of breath) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Confusion SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE v. 3.0 View
Pneumonitis/pulmonary infiltrates SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Pleural effusion (non-malignant) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Adult Respiratory Distress Syndrome (ARDS) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Hemorrhage, pulmonary/upper respiratory, nose SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Aspiration SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Hemorrhage, pulmonary/upper respiratory, bronchopulmonary NOS SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Apnea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Atelectasis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Hiccoughs (hiccups, singultus) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v. 3.0 View
Left ventricular systolic dysfunction SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Valvular heart disease SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Cardiac arrhythmia - other SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Cardiac general - other SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Prolonged QTc interval SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Supraventricular and nodal arrhythmia, sinus bradycardia SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Right ventricular dysfunction (cor pulmonale) SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Pericardial effusion (non-malignant) SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Left ventricular diastolic dysfunction SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Supraventricular and nodal arrhythmia, sinus tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v. 3.0 View
Rash/desquamation SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v. 3.0 View
Petechiae/purpura (hemorrhage/bleeding into skin or mucosa) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v. 3.0 View
Dermatology/skin - other SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v. 3.0 View
Rash: acne/acneiform SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v. 3.0 View
Rash: hand-foot skin reaction SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v. 3.0 View
Pruritus/itching SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v. 3.0 View
Pain, skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v. 3.0 View
Intra-operative injury - other SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications CTCAE v. 3.0 View
Rash: erythema multiforme (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v. 3.0 View
Hemorrhage/bleeding - other SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v. 3.0 View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v. 3.0 View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v. 3.0 View
Thrombosis/thrombus/embolism SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v. 3.0 View
Acute vascular leak syndrome SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v. 3.0 View
Hematoma SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v. 3.0 View
Pain, back SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v. 3.0 View
Pain, extremity-limb SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v. 3.0 View
Pain, buttock SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v. 3.0 View
Pain, muscle SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v. 3.0 View
Pain, joint SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v. 3.0 View
Growth and development - other SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v. 3.0 View
Pain, chest wall SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v. 3.0 View
Thrombosis/embolism (vascular access-related SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications CTCAE v. 3.0 View
Liver dysfunction/failure (clinical) SYSTEMATIC_ASSESSMENT Hepatobiliary disorders CTCAE v. 3.0 View
Hepatobiliary/pancreas - other SYSTEMATIC_ASSESSMENT Hepatobiliary disorders CTCAE v. 3.0 View
Muscle weakness, generalized or specific area (not due to neuropathy), extremity-upper SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v. 3.0 View
PTT (Partial Thromboplastin Time) SYSTEMATIC_ASSESSMENT Investigations CTCAE v. 3.0 View
INR (International Normalized Ratio of prothrombin time) SYSTEMATIC_ASSESSMENT Investigations CTCAE v. 3.0 View
Renal failure SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v. 3.0 View
Cystitis SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v. 3.0 View
ALT, SGPT (serum glutamic pyruvic transaminase) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Glomerular filtration rate SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v. 3.0 View
Urinary frequency/urgency SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v. 3.0 View
Renal/genitourinary - other SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v. 3.0 View
Potassium, serum-low (hypokalemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
AST, SGOT (serum glutamic oxaloacetic transaminase) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Acidosis (metabolic or respiratory) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Allbumin, serum-low (hypoalbuminemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Alkalosis (metabolic or respiratory) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Bilirubin (hyperbilirubinemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Glucose, serum-high (hyperglycemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Sodium, serum-high (hypernatremia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Sodium, serum-low (hyponatremia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Calcium, serum-low (hypocalcemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Lipase SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Alkaline phosphatase SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Anorexia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
GGT (gamma-Glutamyl transpeptidase) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Incontinence, urinary SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v. 3.0 View
Magnesium, serum-high (hypermagnesemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Potassium, serum-ghigh (hyperkalemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Cholecystitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders CTCAE v. 3.0 View
Otitis, middle ear (non-infectious) SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders CTCAE v. 3.0 View
Phosphate, serum-low (hypophosphatemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Tinnitus SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders CTCAE v. 3.0 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Amylase SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Tumor lysis syndrome SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Uric acid, serum-high (hyperuricemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Bicarbonate, serum-low SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Glucose, serum-low (hypoglycemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Fibrinogen SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Creatinine SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Metabolic/Laboratory SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Magnesium, serum-low (hypomagnesemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Pain, vagina SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders CTCAE v. 3.0 View
Calcium, serum-high (hypercalcemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE v. 3.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Pain, throat/pharynx/larynx SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Hemorrhage, GU, iuterus SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders CTCAE v. 3.0 View
Mucositis/stomatitis (clinical exam), oral cavity SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Typhlitis (cecal inflammation) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Colitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Hemorrhage, GI, Oral cavity SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Pain, Abdomen NOS SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Pain, Anus SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Gastrointestinal - Other SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Heartburn/dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Ileus, GI (functional obstruction of bowel, i.e., neuroconstipation) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Proctitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Obstruction, GI, Sotmach SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Distension/bloating, abdominal SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Enteritis (inflammation of the small bowel) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Esophagitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Hemorrhage, GI, Lower GI NOS SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Mucositis/stomatitis (functional/symptomatic), oral cavity SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Pain, rectum SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Perforation, GI, appendix SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Dysphagia (difficulty swallowing) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Pain, oral cavity SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Pain, dental/teeth/peridontal SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Hemorrhage, GI, abdomen NOS SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Gastritis (including bile reflux gastritis) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Pain, stomach SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Mucositis/stomatitis (clinical exam), small bowel SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Mucotitis/stomatitis (functional/symptomatic), esophagus SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Incontinence, anal SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Pain, lip SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v. 3.0 View
Syncope (fainting) SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Pain, head/headache SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Neuropathy: sensory SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Hydrocephalus SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Encephalopathy SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Hemorrhage, CNS SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Neuropathy: motor SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v. 3.0 View
Colitis, infectious (e.g., Clostridium difficile) SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Infection with unknown ANC, urinary tract NOS SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v. 3.0 View
Retinal detachment SYSTEMATIC_ASSESSMENT Eye disorders CTCAE v. 3.0 View
Musculoskeletal/soft tissue - other SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v. 3.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Allergic reaction/hypersensitivity (including drug fever) SYSTEMATIC_ASSESSMENT Immune system disorders CTCAE v. 3.0 View